Wall Street Experts
ver. ZuMIgo(08/25)
Guangzhou LBP Medicine Science & Technology Co., Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 494
EBIT TTM (mln): 22
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
Rok finansowy |
2011 |
2012 |
2013 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
88 |
107 |
143 |
241 |
260 |
306 |
355 |
375 |
439 |
507 |
497 |
471 |
Przychód Δ r/r |
0.0% |
22.5% |
32.7% |
69.1% |
8.0% |
17.6% |
16.0% |
5.7% |
16.9% |
15.6% |
-2.0% |
-5.3% |
Marża brutto |
64.9% |
65.2% |
67.6% |
82.3% |
83.4% |
83.0% |
83.7% |
79.8% |
77.9% |
71.1% |
95.3% |
67.2% |
EBIT (mln) |
27 |
30 |
40 |
47 |
61 |
74 |
89 |
100 |
89 |
39 |
474 |
11 |
EBIT Δ r/r |
0.0% |
9.4% |
34.6% |
16.7% |
29.1% |
22.6% |
19.4% |
12.8% |
-11.2% |
-56.3% |
1119.8% |
-97.7% |
EBIT (%) |
31.2% |
27.8% |
28.2% |
19.5% |
23.3% |
24.3% |
25.0% |
26.7% |
20.3% |
7.7% |
95.3% |
2.3% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
-0 |
0 |
-1 |
-6 |
0 |
1 |
0 |
1 |
EBITDA (mln) |
31 |
33 |
46 |
70 |
74 |
90 |
101 |
112 |
104 |
75 |
0 |
51 |
EBITDA(%) |
35.6% |
30.7% |
31.9% |
29.0% |
28.6% |
29.5% |
28.6% |
29.8% |
23.8% |
14.7% |
0.0% |
10.8% |
Podatek (mln) |
5 |
5 |
6 |
8 |
10 |
12 |
14 |
16 |
13 |
-1 |
-0 |
-5 |
Zysk Netto (mln) |
27 |
28 |
38 |
46 |
48 |
61 |
74 |
85 |
80 |
29 |
40 |
21 |
Zysk netto Δ r/r |
0.0% |
2.2% |
38.6% |
19.8% |
5.0% |
27.2% |
20.4% |
14.5% |
-5.9% |
-63.2% |
37.4% |
-47.2% |
Zysk netto (%) |
31.0% |
25.8% |
27.0% |
19.1% |
18.6% |
20.1% |
20.8% |
22.6% |
18.2% |
5.8% |
8.1% |
4.5% |
EPS |
2.71 |
0.4 |
0.55 |
0.66 |
0.69 |
0.88 |
0.79 |
0.91 |
0.85 |
0.31 |
0.44 |
0.23 |
EPS (rozwodnione) |
2.71 |
0.4 |
0.55 |
0.66 |
0.69 |
0.88 |
0.79 |
0.91 |
0.85 |
0.31 |
0.44 |
0.22 |
Ilośc akcji (mln) |
10 |
69 |
70 |
70 |
70 |
70 |
93 |
93 |
93 |
93 |
91 |
94 |
Ważona ilośc akcji (mln) |
10 |
69 |
70 |
70 |
70 |
70 |
93 |
93 |
93 |
95 |
91 |
94 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |